Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function
Randomized Controlled Trial to Evaluate Efficacy of Psychological Support Based on Positive Suggestions (PSBPS) on Mental Health Morbidity and Cognitive Function
1 other identifier
interventional
274
1 country
1
Brief Summary
The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2019
CompletedFirst Posted
Study publicly available on registry
August 5, 2019
CompletedStudy Start
First participant enrolled
August 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedMay 14, 2025
May 1, 2025
5.4 years
July 25, 2019
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
minimal important change in hospital anxiety and depression scale - Anxiety
This outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the two intervention groups within 96 hours after ICU discharge and at 6 months follow up
within 96 hours after ICU discharge and 3 months after hospital discharge
Secondary Outcomes (1)
minimal important change in hospital anxiety and depression scale-Depression
within 96 hours after ICU discharge and 3 months after hospital discharge
Other Outcomes (3)
minimal important change in Impact of Event Scale-Revised
within 96 hours after ICU discharge and 3 months after hospital discharge
statistically significant improvement in MoCA-blind
within 96 hours after ICU discharge and 3 months after hospital discharge
EQ-5D-3L
within 96 hours after ICU discharge and 3 months after hospital discharge
Study Arms (2)
No Intervention
NO INTERVENTIONDoula
EXPERIMENTALInterventions
Eligible patients will be randomized at the earliest possible time after meeting inclusion criteria. Patients will be randomized 1:1 to intervention by ICU doulas or a non-intervention arms stratified by ICU location. Both intervention and controls will receive standard medical care at the discretion of the ICU team. The intervention arm will receive PSBPS as soon as feasible and continue on a daily basis. Doulas will also liaise with family, the team, and with the nursing staff. Both intervention and standard of care arms will complete follow-up questionnaires measuring symptoms of anxiety, depression, acute stress and cognitive function after ICU discharge and at 3 months follow up by phone. All the patients randomized to the intervention arm will receive the same intervention.
Eligibility Criteria
You may qualify if:
- \- Critically ill adult patients (age \>18) requiring non-invasive ventilation, high flow O2 or mechanical ventilation and expected to stay \>48 hours.
You may not qualify if:
- history of dementia
- intellectual disability
- suicide attempt
- psychotic disorders such as schizophrenia
- acute alcohol/substance intoxication or withdrawal
- severe metabolic encephalopathy
- patients on comfort care
- Patients not expected to survive the hospital stay
- Non-English speaking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 25, 2019
First Posted
August 5, 2019
Study Start
August 30, 2019
Primary Completion
January 31, 2025
Study Completion
March 15, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05